Furthermore, volasertib 69, shown in Fig. 13, is a PLK1 kinase inhibitor that induces pyroptosis in acute myeloid leukemia and many other tumors through caspase-3/GSDME/Bax activation [151, 185]. Here, GSDME is linked to acute myeloid leukemia.